Sign Up
Stories
Altimmune Faces Investor Investigation
Share
AlloVir Class Action Lawsuit Filed
AlloVir Faces Class Action Allegations
AlloVir Faces Class Action Lawsuit
Overview
API
Rosen Law Firm investigates Altimmune for misleading business information, potentially leading to a class action lawsuit for investors who suffered stock price drop due to drug competitiveness concerns.
Ask a question
How could this event influence the pharmaceutical industry's approach to drug competitiveness disclosures?
How might the investigation impact Altimmune's reputation and future investor trust?
What measures could Altimmune take to address the concerns raised about pemvidutide?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage